Melanie_Matheu.jpg

Melanie Matheu, PhD

Founder, CEO

Dr. Matheu founded Prellis Biologics in October 2016 to solve the systemic problem in bioprinting technologies: the inability to match the resolution and printed feature size necessary to build a physiologic organ or tissue system. Today Prellis Biologics has achieved the fastest high resolution bioprinting ever reported by using holographic projection of multi-photon lasers and can replicate true-to-form complex tissue structures such as the human kidney nephron and liver sinusoids. Dr. Matheu is a trained Immunologist who pioneered immune cell imaging in a variety of living tissues and the characterization of immune responses that are dependent on cell motility and cell-cell interactions.

During her academic career, Dr. Matheu authored numerous peer-reviewed publications and a book chapter detailing methods and approaches for high-resolution 3D imaging in living tissues, with a focus on immune responses. In her free time Dr. Matheu can be found backcountry skiing in the winter with her german shepherd, and trail running or surfing in the summer.

prellis-white-icon-01.png
Building The 3D World Together
© Prellis Biologics 2020
All rights reserved.
  • Twitter
  • Instagram
  • LinkedIn